How many institutions held IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share in Q2 2025?

23 institutional investors reported IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX)

Q: What does CUSIP 45258H106 represent in this 13F holders report?

CUSIP 45258H106 is the security identifier for IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258H106

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 53,060,943
Total 13F shares: 2,262,228
Share change: -656,214
Total reported value: $4,682,595
Price per share: $2.07
Number of holders: 23
Value change: -$1,044,152
Number of buys: 10
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 45258H106?
CUSIP 45258H106 identifies IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 45258H106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Yekaterina Chudnovsky	3/4/5	Director, 10%+ Owner	— mixed-class rows	3,274,076 mixed-class rows	$6,449,741	—	20 Jun 2025	3/4/5
Vladimir P. Torchilin	3/4/5	Scientific Co-Founder	— class O/S missing	905,200	$4,230,905	—	20 Dec 2021	3/4/5
Sean Senn	3/4/5	Under 10% owner	— class O/S missing	899,800	$4,205,665	—	14 Jul 2022	3/4/5
Carey Ng	3/4/5	Director	— mixed-class rows	1,078,221 mixed-class rows	$2,079,989	—	20 Jun 2025	3/4/5
Jason Hsu	3/4/5	Director	— mixed-class rows	976,000 mixed-class rows	$1,876,570	—	20 Jun 2025	3/4/5
Bleichroeder LP	13F	Company	1.6%	850,000	$1,428,000	—	31 Mar 2025	13F
Cable Car Capital, LP	13F	Company	1.5%	779,358	$1,309,321	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	1.3%	698,537	$1,173,542	—	31 Mar 2025	13F
Helen C. Adams	3/4/5	Director	— mixed-class rows	207,754 mixed-class rows	$347,760	—	20 Jun 2025	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	160,742	$270,088	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.18%	95,262	$160,040	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.16%	82,292	$138,251	—	31 Mar 2025	13F
Magda Marquet	3/4/5	Director	— mixed-class rows	99,092 mixed-class rows	$131,523	—	20 Jun 2025	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	55,262	$92,840	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.08%	42,960	$72,173	—	31 Mar 2025	13F
Private Advisor Group, LLC	13F	Company	0.06%	31,225	$52,458	—	31 Mar 2025	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.06%	29,300	$49,224	—	31 Mar 2025	13F
Jane Buchan	3/4/5	Director	— mixed-class rows	55,455 mixed-class rows	$44,685	—	20 Jun 2025	3/4/5
SBI Securities Co., Ltd.	13F	Company	0.03%	17,500	$29,400	—	31 Mar 2025	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.03%	17,040	$29,000	—	31 Mar 2025	13F
XTX Topco Ltd	13F	Company	0.02%	12,833	$21,559	—	31 Mar 2025	13F
Focus Partners Wealth	13F	Company	0.02%	11,900	$19,992	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.02%	11,824	$19,864	—	31 Mar 2025	13F
FNY Investment Advisers, LLC	13F	Company	0.02%	11,250	$18,000	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.02%	10,121	$17,004	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	471	$791	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	330	$554	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	120	$202	—	31 Mar 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0%	80	$134	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	35	$59	—	31 Mar 2025	13F

Institutional Holders of Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) as of Q2 2025

As of 30 Jun 2025, Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,262,228 shares. The largest 10 holders included Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, BlackRock, Inc., Private Advisor Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P.. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.